Brief: Theranexus Publishes Scientific Article On Mechanism Of Action Of Drug Candidate THN102
May 22 (Reuters) - THERANEXUS SA ALTHX.PA :
* THIS WORK MAPS OUT EFFECTS OF THN102 ON BRAIN
* PUBLISHES SCIENTIFIC ARTICLE ON MECHANISM OF ACTION OF
DRUG
CANDIDATE THN102 IN INTERNATIONAL JOURNAL OF
NEUROPSYCHOPHARMACOLOGY
* ADMINISTRATION OF THN102 INTENSIFIES METABOLIC ACTIVITY IN
COMPARISON TO MODAFINIL ALONE
Source text for Eikon: ID:nACT53397
Further company coverage: ALTHX.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 59 772 0920;))
Recent news on Thx Pharma SA
See all newsBrief: Theranexus And BBDF Announce Final And Positive Safety And Efficacy Data In The Phase I/II Trial Testing Batten-1
Brief: Theranexus End-Dec Total Available Funds Stood At EUR 4.9 Mln
Brief: Theranexus Declares Encouraging Prelim Results For Batten Disease Drug
Brief: Theranexus And BBDF Granted Positive Opinion By EMA For Design Of Batten-1 Phase III Trial
Brief: Theranexus And BBDF Win FDA Approval On Endpoints For Phase III Trial To Evaluate Batten-1 In CLN3 Batten Disease